Inovio Pharmaceuticals, Inc.

LSE:0A43 Stock Report

Market Cap: US$106.2m

Inovio Pharmaceuticals Balance Sheet Health

Financial Health criteria checks 4/6

Inovio Pharmaceuticals has a total shareholder equity of $73.5M and total debt of $0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are $107.1M and $33.5M respectively.

Key information

0%

Debt to equity ratio

US$0

Debt

Interest coverage ration/a
CashUS$84.80m
EquityUS$73.54m
Total liabilitiesUS$33.52m
Total assetsUS$107.06m

Recent financial health updates

No updates

Recent updates

Financial Position Analysis

Short Term Liabilities: 0A43's short term assets ($91.3M) exceed its short term liabilities ($23.5M).

Long Term Liabilities: 0A43's short term assets ($91.3M) exceed its long term liabilities ($10.0M).


Debt to Equity History and Analysis

Debt Level: 0A43 is debt free.

Reducing Debt: 0A43 has no debt compared to 5 years ago when its debt to equity ratio was 194%.


Balance Sheet


Cash Runway Analysis

For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.

Stable Cash Runway: 0A43 has less than a year of cash runway based on its current free cash flow.

Forecast Cash Runway: 0A43 has less than a year of cash runway if free cash flow continues to reduce at historical rates of 7.5% each year


Discover healthy companies